TABLE 1.
Variables | FBTCS− (n = 37) | FBTCS+ (n = 89) | HC (n = 60) | p |
---|---|---|---|---|
Age, median [IQR], years | 25 [21, 28] | 25 [22, 31] | 24 [20, 29] | 0.209* |
Gender, n (%) | 0.243 # | |||
Male | 17 (45.9) | 51 (57.3) | 38 (63.3) | |
Female | 20 (54.1) | 38 (42.7) | 22 (36.7) | |
TIV, median [IQR], cm3 | 1465.20 [1360.96, 1556.85] | 1480.50 [1411.39, 1602.28] | 1534.40 [1445.34, 1644.40] | 0.075* |
Lateralization, n (%) | 0.936 # | |||
Left | 19 (51.4) | 45 (50.6) | NA | |
Right | 18 (48.6) | 44 (49.4) | NA | |
Febrile seizure history, n (%) | 0.051 # | |||
Yes | 15 (40.5) | 53 (59.6) | NA | |
No | 22 (59.5) | 36 (40.4) | NA | |
Seizure frequency, n (%) | 0.704 # | |||
Frequent | 19 (27.9) | 49 (72.1) | NA | |
Infrequent | 18 (31.0) | 40 (69.0) | NA | |
Seizure onset age, median [IQR], years | 15 [9, 18] | 14 [8, 18] | NA | 0.332 § |
Duration, median [IQR], years | 10 [6, 14] | 12 [7, 17] | NA | 0.155 § |
Abbreviations: FBTCS−, without focal to bilateral tonic–clonic seizures; FBTCS+, with focal to bilateral tonic–clonic seizures; HC, healthy control; IQR, interquartile range; TIV, total intracranial volume.
Kruskal–Wallis H test.
Chi‐square test.
Mann–Whitney U test.